Thrive Capital

Thrive Capital’s thesis centers on backing internet, software, and technology‑enabled companies that can define or dominate a large market. Key sectors include fintech/payments (Stripe, Nubank), AI and foundational models (OpenAI), developer tools and enterprise infrastructure (Airtable, Benchling), defense & space technology (Anduril), consumer platforms (Instagram, A24), and health‑tech data platforms. The firm is stage‑agnostic, investing from early seed rounds through late‑stage growth, tenders, and secondary transactions, often leading or co‑leading large financings to secure concentrated ownership. Geography is global, with a strong U.S. base but notable out‑of‑country bets in Latin America and Europe. Thrive avoids small, low‑growth markets and incremental products lacking a clear pathway to category leadership. Its core belief is that deep partnership with exceptional founders, high conviction concentration, and a long‑term view (thinking to 2030) generate outsized value, allowing the firm to underwrite volatility in pursuit of transformative outcomes.

Thrive Capital invests when it sees a company capable of creating or dominating a large, technology‑enabled category. Partners stress founder‑market fit and the potential for long‑term compounding over short‑term revenue metrics. They favour businesses with clear network effects, platform leverage, or frontier tech (AI, fintech, developer tools). Deal‑breakers include ideas targeting small, niche markets or products that lack differentiation and are easily commoditized. While traction matters, the firm is comfortable leading large rounds for pre‑revenue AI platforms if the team and technology are exceptional, and it backs later‑stage firms with strong revenue if the category leadership narrative holds. The decision framework is therefore weighted heavily toward market size and founder vision, with traction used as a supporting signal rather than a primary gate.

• OpenAILead
  A foundational AI platform at massive scale; Thrive organized and led the 2023/2024 employee tender offers, matching its focus on large-scale technology-enabled companies.
• DatabricksLead
  Category-defining data and AI company; Thrive led the 2024 Series J, fitting Thrive's growth-stage conviction bets.
• RampLead
  Fintech/enterprise software reshaping finance operations; Thrive is a long-time investor and co-led the 2023 Series C. Note: the Aug 2023 $300M Series D was led by Lightspeed, not Thrive.
• GreenhouseLead
  Enterprise recruiting software with strong market traction; Thrive led the 2015 $35M Series C.
• BenchlingLead
  Life-sciences R&D cloud platform; Thrive led the $7M 2016 round (Series B), reflecting its interest in high-impact software platforms for specialized markets.
• AndurilLead
  Defense technology with heavy AI/software components; Thrive co-led the March 2026 $4B round with Andreessen Horowitz at a $60B valuation.
• OpenEvidenceLead
  Medical AI platform achieving rapid revenue scale; Thrive co-led the 2026 Series D, fitting its focus on AI-enabled enterprise solutions.
• Cedar
  Patient financial engagement fintech; Thrive participated alongside other lead investors, matching its broader healthcare/fintech thesis.

• 
  Founders Fund

  AndurilRamp
• 
  Lux Capital

  BenchlingDatabricks
• 
  8VC

  Anduril
• 
  Andreessen Horowitz

  Databricks
• 
  Benchmark

  Benchling
• 
  ICONIQ Growth

  Ramp
• 
  Insight Partners

  Databricks
• 
  Lightspeed Venture Partners

  Ramp
• 
  Menlo Ventures

  Benchling